1. "2014"
  2. "Haematologica"
Formats
  1. Meeting Abstract (25)
  2. Journal Article (10)
Groups
  1. Department of Medicine (30)
  2. Hematologic Malignancies, Division of (30)
  3. Center for Hematologic Malignancies (28)
  4. GSK Faculty (13)
  5. Adult Leukemia (12)
  6. Executive Committee, Center for Hematologic Malignancies (9)

More Groups

People
  1. Andrew Zelenetz (5)
  2. Omar Abdel-Wahab (5)
  3. Ross Levine (5)
  4. Martin Tallman (4)
  5. Michel Sadelain (3)
  6. Raajit Rampal (3)

More People

Years
  1. 2014 (35)
Publications
  1. Haematologica (35)
Publishers
  1. Ferrata Storti Foundation (35)

Results (35)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Smoldering multiple myeloma: Special considerations surrounding treatment on versus off clinical trials
    Journal Article

    Manasanch, E. E.; Korde, N.; Mailankody, S.; Tageja, N.; Bhutani, M.; Roschewski, M.; Landgren, O.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Efficacy of idelalisib in Cll subpopulations harboring del(17p) and other adverse prognostic factors: Results from a phase 3, randomized, double-blind, placebo-controlled trial
    Meeting Abstract

    Stilgenbauer, S.; Coutre, S. E.; Furman, R. R.; Cheson, B. D.; Pagel, J. M.; Hillmen, P.; Barrientos, J. C.; Zelenetz, A. D.; Kipps, T. J.; Flinn, I. W.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • ABT-199 (Gdc-0199) in relapsed/refractory chronic lymphocytic leukemia and small lymphocytic lymphoma: High response rates among patients with high risk disease features including unmutated IGHV
    Meeting Abstract

    Seymour, J. F.; Davids, M. S.; Pagel, J. M.; Kahl, B. S.; Wierda, W. G.; Puvvada, S.; Gerecitano, J. F.; Kipps, T. J.; Anderson, M. A.; Huang, D. C.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Quizartinib (Ac220) in patients with flt3-Itd(+) relapsed or refractory acute myeloid leukemia: Final results of a randomized phase 2 study
    Meeting Abstract

    Russell, N.; Tallman, M. S.; Goldberg, S.; Perl, A. E.; Marie, J. P.; Martinelli, G.; Larson, R. A.; Schiller, G.; Trone, D.; Gammon, G.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Molecular predictors of response to decitabine in chronic myelomonocytic leukemia
    Meeting Abstract

    Rossi, A.; Valencia, A.; Abdel-Wahab, O.; Masala, E.; Buchi, F.; Sanna, A.; Bosi, A.; Levis, A.; Allione, B.; Lunghi, M.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Integrated genomic analysis illustrates the central role of jak-stat pathway activation in myeloproliferative neoplasm pathogenesis
    Meeting Abstract

    Rampal, R.; Al-Shahrour, F.; Abdel-Wahab, O.; Patel, J.; Brunel, J. P.; Mermel, C.; Bass, A.; Pretz, J.; Ahn, J.; Hricik, T.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Requirement for CDK6 in MLL-rearranged acute myeloid leukemia
    Meeting Abstract

    Placke, T.; Faber, K.; Nonami, A.; Putwain, S.; Salih, H.; Heidel, F.; Kramer, A.; Root, D.; Barbie, D.; Armstrong, S.; more...
    Haematologica (2014)

    Fulltext@MSK | Save
  • Phase I trial of autologous Cd19-targeted car-modified T cells as consolidation after purine analog-based first-line therapy in patients with previously untreated cll
    Meeting Abstract

    Park, J. H.; Riviere, I.; Wang, X.; Bartido, S.; Sadelain, M.; Brentjens, R. J.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Artesunate, an antimalarial drug displays preclinical activity in Flt3 mutated leukemia and synergises with arac
    Meeting Abstract

    Mony, U.; Hoya-Arias, R.; Ambati, S.; Pera, B.; Dogan, Y.; Peguero, E.; Shieh, J.H.; Moore, M.
    Haematologica (2014)

    Fulltext@MSK | Save
  • Genetic studies reveal Jak2 is not essential for platelet production
    Meeting Abstract

    Meyer, S. C.; Keller, M. D.; Woods, B. A.; LaFave, L. M.; Bastian, L.; Kleppe, M.; Bhagwat, N.; Marubayashi, S.; Levine, R. L.
    Haematologica (2014)

    Fulltext@MSK | Save